Stock Movers: Intel Surges on Nvidia Deal, Novo Rises on Drug Study, Cracker Barrel Falls

Intel's Surge on Nvidia Partnership

• 🚀 Intel (INTC) shares experienced their biggest intraday jump since 1987, rising about 25%.
• 💡 This surge follows Nvidia's announcement of a $5 billion investment and a plan to co-design chips for PCs and data centers.
• ⚠️ Despite the rebound, the stock's performance over the last two years is described as resembling an EKG, indicating past volatility.

Novo Nordisk's Diabetes Drug Success

• 📈 Novo Nordisk ADRs (NVO) rallied over 6%, marking their largest jump since August.
• 🔬 A study indicated that Novo's diabetes drug, Ozempic, outperformed Eli Lilly's older drug, Trulicity.
• ✅ Medicare patients using Ozempic were found to be 23% less likely to experience a heart attack or stroke.
• ⚠️ Despite today's gains, Novo Nordisk is still down 53% over the past 12 months.
• 💊 The future potential of an oral pill format for these drugs is highlighted as a way to broaden the market and potentially lower costs.

Cracker Barrel's Weak Forecast

• 📉 Cracker Barrel (CBRL) shares are under pressure, trading at their lowest level since early May.
• 📊 The company projected revenue for fiscal 2026 to be between $3.35 billion and $3.45 billion, missing analyst expectations of around $3.5 billion.
• ⚠️ Lingering issues related to a past rebranding backlash are cited as a factor, with data showing notable drops in same-store sales and foot traffic.